However, the anti-adipogenic and anti-obesity effects of SFEN, and its underlying mechanisms of action, including which adipogenic transcription factors (e.g., C/EBPβ) are important, are still unclear. The gene discussed is CEBPB; the disease is obesity due to melanocortin 4 receptor deficiency.